Victor P. Ghidu, Ph.D.

Before joining Morgan Lewis, Victor practiced patent law at a boutique IP firm in the greater Philadelphia area. Victor brings to his practice a wealth of experience as a research scientist in organic and medicinal chemistry, but also as a technical sales specialist for a large multinational specialty chemicals corporation earlier in his career. Victor is fluent in Romanian.

Victor has co-authored several publications (selected: Ghidu et al., “A new and efficient synthetic route for the anxiolytic agent CL285032” Bioorg. Med. Chem. Lett., 2011, 21(1), 259-261; Ghidu et al., “Combined Chemical and Biosynthetic Route to Access a New Apoptolidin Congener” Org. Lett., 2009, 11 (14), 3032-3034; Ghidu et al., “Synthesis and Evaluation of the Cytotoxicity of Apoptolidinones A and D” J. Org. Chem., 2008, 73 (13), 4949-4955; Pearson and Ghidu, “A New Paradigm for Cationic Cyclization of Iron Tricarbonyl Diene Complexes with Pendant Alkenes and Arenes” Org. Lett., 2002, 4 (23), 4069-4071).

Victor is credited as a co-inventor on two patent applications of which one was recently granted a US Patent: US 10,131,637 (WO 2014/150395), and WO 2015/054117.